Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 4 I, 1998, Pages 470-474

  Wilson, Andrew M ^a   McFarlane, Lesley C ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adrenocorticotrophic hormone; Beclomethasone dipropionate; Cortisol; Fluticasone propionate; Hypothalamic pituitary adrenal axis; Intranasal corticosteroids; Triamcinolone acetonide

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOTROPIN; FLUTICASONE PROPIONATE; NASACORT AQ; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG MIXTURE; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS;

ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ADULT; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; SINGLE-BLIND METHOD;

EID: 0031959073     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70354-9     Document Type: Article

References (25)

1. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993;48:476-90.
2. Foresi A, Pelucchi A, Cherson G, Mastropasqua B, Chiappario A. Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-82.
3. Bernstein DI, Creticos PS, Busse WW, Cohen R, Graft DF, Howland WC, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996;97:749-55.
4. Bronsky EA, Dockhorn RJ, Meltzer EO, Shapiro G, Boltansky H, Laforce C, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:915-21.
5. Van As A, Bronsky E, Grossman J, Meltzer E, Ratner P, Reed C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991;67:156-62.
6. Brannan MD, Herron JM, Reidenberg P, Affrime MB. Lack of hypothalamic-pituitary-adrenal axis suppression with once daily or twice daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. Clin Ther 1995;17:637-47.
7. Howland WC, Dockhron MD, Gillman S, Gross GN, Hille D, Simpson B, et al. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J Allergy Clin Immunol 1996;98:32-8.
8. Lipworth BJ, Seckl JR. Measures for detecting systemic bioactivity with inhaled and intra-nasal corticosteroids. Thorax 1997;52:476-82.
9. Newman PS, Moren F, Clarke SW. Deposition pattern from a nasal pump spray. Rhinology 1987;25:77-82.
10. Clark DJ, Lipworth BJ. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 1997;52:55-8.
11. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996;42:697-705.
12. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, et al. Low-dose adrenocorticotrophin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995;80:1243-6.
13. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996;44:151-6.
14. Knutsson U, Stierna P, Marcus C, Carlstedt-Duke J, Calrstrom K, Bronnegard M. Effects of intra-nasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995; 144:301-10.
15. Philips GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84(suppl A):19-23.
16. English AF, Neate MS, Quint DJ, Sareen M. Biological activities of some corticosteroids used in asthma [abstract]. Am J Resp Crit Care Med 1994:149(suppl):A212.
17. Hogger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994;59:597-602.
18. Grahnen A, Eckernas SA, Brudin RM, Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1994;38:521-5.
19. Lonnebo A, Grahnen A, Jansson B, Ling-Anderson A, Brudin RM, Eckernas SA. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol 1996;49:459-63.
20. Thorsson L, Dahlstom K, Edsbacker S, Kallen A, Paulson J, Wiren JE. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997;43:155-61.
21. Wurthwein G, Rehder S, Rohdewald P. Lipophilicity and receptor affinity of glucocorticoids. Pharm Ztg, Wiss 1992;4:161-7.
22. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled fluticasone propionate and budesonide. Eur Respir J 1996;9:1427-32.
23. Wilson AM, McFarlane LC, Lipworth BJ. Dose-response effects for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in asthmatic patients. Am J Respir Crit Care Med 1997;156:1274-7.
24. Brown PH, Blundell G, Greening AP, Crompton GK. Screening for hypothalmo-pituitary-adrenal axis suppression in asthmatics taking high doses of inhaled corticosteroids. Respir Med 1991;85: 511-6.
25. McIntyre HD, Mitchell-CA, Bowler SD, Armstrong JG, Wooler JA, Cowley DM. Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hr specimens. Thorax 1995;50:1280-4.